Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Progressive Insights into 3D Bioprinting for Corneal Tissue Restoration

Namli I., Gupta D., Singh YP., Datta P., Rizwan M., Baykara M.

Narrative Review on Hip, published in Adv Healthc Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Adv Healthc Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
40999832
PMCID
PMC12817122
DOI
10.1002/adhm.202503372
Citations
7

Abstract (original English)

The complex architecture of the cornea, characterized by specifically organized collagen fibrils and distinct cellular layers, poses significant challenges for traditional tissue engineering strategies to replicate its native function. 3D Bioprinting offers a promising solution by enabling the precise, layer-by-layer fabrication of corneal tissues, closely mimicking the essential characteristics needed for vision restoration and long-term graft success. This Review critically examines the key biomechanical, optical, and structural attributes of the cornea necessary for its effective engineering and accurate 3D bioprinting. It provides a comprehensive overview of different 3D bioprinting modalities utilized for corneal tissue engineering and offers insights into potential improvements. Additionally, it details the requirements for a corneal bioink suitable for 3D bioprinting, ensuring it meets the necessary corneal functions. The Review also delves into the current challenges in 3D bioprinting of corneal tissue and proposes potential solutions to successfully replicate the complex architecture and function of the cornea. Furthermore, it explores innovative approaches such as the use of induced pluripotent stem cells, gene therapy, and cornea-on-a-chip technologies, which hold promise for advancing corneal regeneration. The Review aims to visualize the future of corneal 3D biopri

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
CorneaAnimalsHumansTissue EngineeringTissue ScaffoldsBioprintingPrinting, Three-Dimensional

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research